Fluvoxamine for the early treatment of SARS-CoV-2 Infection: a review of current evidence.
2 Dec, 2021 | 10:04h | UTCFluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence – Drugs
Related:
Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence – Drugs
Related: